Publications

Research Summary

Creating Corporate Value Added

By: Joseph L. Bower

In response to dramatic changes in the business environment--hypercompetition in many traditional industries, short product life cycles, and new competitors based in emerging nations--successful companies have responded by repositioning themselves in the global markets... View Details

September 2020
Case

Merck: COVID-19 Vaccines

By: Willy C. Shih

COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details

Keywords: Vaccines; COVID-19 Pandemic; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Technological Innovation; Business Strategy; Product Launch; Pharmaceutical Industry

September 2006 (Revised November 2007)
Case

Patrimonio Hoy: A Financial Perspective

By: Arthur I Segel, Michael Chu and Gustavo A. Herrero

Patrimonio Hoy, a program targeting the housing needs of low-income families launched by CEMEX, a major Mexican corporation and a leading global cement company, has gone from a market research project to a highly visible initiative in 22 cities and has earned public... View Details

Keywords: Diversification; Housing; Income; Corporate Social Responsibility and Impact; Emerging Markets; Finance; Mexico

Article

Operational Efficiency and Effective Management in the Catheterization Laboratory

By: Grant W. Reed, Michael L. Tushman and Samir R. Kapadia

Operational efficiency is a core business principle in which organizations strive to deliver high-quality goods or services in a cost-effective manner. This concept has become increasingly relevant to cardiac catheterization laboratories, as insurers move away from... View Details

Keywords: Cath Lab; Catheterization Laboratory; Health Care and Treatment; Performance Efficiency; Management; Performance Productivity; Cost Management; Health Industry

Find at Harvard

Read Now

January 2019 (Revised November 2019)
Case

Ajeej Capital: Investing in Emerging Markets

By: Luis M. Viceira and Eren Kuzucu

In October 2007, Tarek Sakka and Fouad Dajani launched Ajeej Capital, the first independent investment advisory in the MENA region. Fittingly named ajeej, an Arabic word that translates to “growth and propagation in a chaotic setting,” the firm’s AUM grew from $20... View Details

Keywords: Security Selection; Investments; Growth; Culture; UAE; Finance; Asset Management; Emerging Markets; Capital Markets; Investment; Growth Management; Risk Management; Middle East; Saudi Arabia; Dubai; United Arab Emirates; Egypt; North Africa

September 2022
Article

Find and Replace: R&D Investment Following the Erosion of Existing Products

By: Joshua L. Krieger, Xuelin Li and Richard T. Thakor

How do innovative firms react when existing products experience negative shocks? We explore this question with detailed project-level data from drug development firms. Using FDA Public Health Advisories as idiosyncratic negative shocks to approved drugs, we first... View Details

Keywords: R＆D Investments; Drug Development; Product Shocks; M＆A; Biopharmaceutical Industry; FDA; System Shocks; Research and Development; Investment; Decision Making; Pharmaceutical Industry

2022
Report

The First Four Healthy Building Strategies Every Building Should Pursue to Reduce Risk from COVID-19

By: Joseph G. Allen, Emily Jones, Marissa V. Rainbolt, Linsey C. Marr, David Michaels, Leslie R. Cadet, Shelly L. Miller, Meira Levinson, Lidia Morawska, Richard L. Corsi, Nira R. Pollock, Yuguo Li, Alasdair P.S. Munro, Kelly Grier, Qingyan Chen, John D. Macomber and Xiaodong Cao

Understanding of the most probable transmission routes and identifying the risk environments for disease spread should always be among the first critical steps in the response to future disease threats. This is one of the most vital public health lessons of the... View Details

Keywords: Health Pandemics; Buildings and Facilities; Risk and Uncertainty; Health Industry; Health Industry; Health Industry

Read Now

16 Dec 2015
Research & Ideas

What Happens When Zambian Schoolgirls Receive Negotiation Training

2009, Harvard Business School Professor Kathleen McGinn has developed keen insight into the exigent nature of such challenges. Her experiences there prompted her to study how teaching communication and negotiation skills at critical developmental junctures might... View Details

Keywords: Re: Kathleen L. McGinn

2022
Working Paper

The Lifesaving Benefits of Convenient Infrastructure: Quantifying the Mortality Impact of Abandoning Shallow Tubewells Contaminated by Arsenic in Bangladesh

By: Nina Buchmann, Erica Field, Rachel Glennerster and Reshmaan Hussam

We document the consequences of a public health campaign which led to the sudden abandonment of local water infrastructure by one-fifth of Bangladesh’s population. Households who experienced quasi-randomly distributed arsenic contamination, and thus were likely to... View Details

Keywords: Child Mortality; Arsenic; Unintended Consequences; Health Disorders; Safety; Outcome or Result; Bangladesh

Read Now

13 Feb 2024
Cold Call Podcast

Apple’s Dilemma: Balancing Privacy and Safety Responsibilities

Keywords: Re: Nien-he Hsieh & Henry W. McGee

September 2012 (Revised August 2015)
Case

Shanghai Pharmaceuticals

By: Regina E. Herzlinger and Natalie Kindred

Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details

Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Health Industry; Health Industry; Shanghai; United States; Europe

07 Jan 2002
Research & Ideas

How Marketing Can Reduce Worldwide Poverty

On the face of it, social marketing is a cinch. Here's one scenario. You as a marketer want people who are living in poverty to take better care of their health. So, given your profession, what do you do? You can persuade them—through View Details

Keywords: by Martha Lagace

October 2020
Teaching Plan

Merck: COVID-19 Vaccines

By: Willy C. Shih

COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details

Keywords: Vaccines; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Research and Development; Business Strategy; Pharmaceutical Industry; United States

28 Feb 2017
First Look

First Look at New Research, February 28

important implications for many platform firms operating in today’s digital economy. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52315 Harvard Business School Case 717-416 DO & CO: Gourmet Entertainment This case is about a View Details

Keywords: Sean Silverthorne

27 Nov 2012
Working Paper Summaries

No Margin, No Mission? A Field Experiment on Incentives for Pro-Social Tasks

Keywords: by Nava Ashraf, Oriana Bandiera & Kelsey Jack

18 Mar 2008
Working Paper Summaries

Modeling Expert Opinions on Food Healthiness: A Nutrition Metric

Keywords: by Jolie Mae Martin, John Leonard Beshears, Katherine Lyford Milkman, Max H. Bazerman & Lisa Sutherland; Retail

January 2024
Article

Cost of Exempting Sole Orphan Drugs from Medicare Negotiation

By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome

Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details

Keywords: Health Care and Treatment; Insurance; Price; Health Industry

Find at Harvard

April 2023 (Revised July 2023)
Case

Fermenting Accounting Problems at Vermont Kombucha Corp.

By: Tatiana Sandino and Marshal Herrmann

Founded in 2005, Vermont Kombucha Corp. (V-Ko) was an early mover in the fledgling U.S. market for kombucha, a drink brewed for its health benefits. Early on, the company captured more than 90% of market share. Under the leadership of its founder and CEO, Joe Williams,... View Details

Keywords: Going Public; Business Model; Financial Reporting; Ethics; Corporate Governance; Stock Shares; Food and Beverage Industry